It may support the direct effect of ω-3 FAs on IGF-1 and fuel the hypothesis that oral supplementation of ω-3 FAs may directly affect pathophysiological pathways of acne, such as sebum production, by lowering IGF-1 levels [52,53,54]. The gene discussed is IGF1; the disease is acne.